Bayer Zydus Pharma
Bayer India operates as the Indian pharmaceutical subsidiary of Bayer AG, marketing first-in-class innovative therapies across cardiovascular, diabetes, kidney, women's health, oncology, and ophthalmology through healthcare providers, pharmacies, and digital channels.
- Company typePublic
- Founded1863
- HeadquartersThane, India
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bayer Zydus Pharma does
Bayer Zydus Pharma, as represented in the available source material, operates as the Indian pharmaceutical subsidiary of Bayer AG (Germany), introduced into India in the early 1900s. The business focuses on marketing and distributing first-in-class, innovative pharmaceutical therapies from Bayer's global portfolio across six key therapeutic areas: Cardiovascular Health, Diabetes, Kidney Health, Women's Healthcare, Oncology, and Ophthalmology. The company claims leadership positions for its global innovative brands in each of these areas within the Indian market and emphasizes a dual strategy of innovation and patient access, given India's disease burden across the targeted specialties and its 1.46 billion population representing roughly one-fifth of the world's people.
The core technology and operational backbone is a comprehensive pharmacovigilance framework staffed by over 1,000 global experts that continuously monitors Bayer's medicines and medical devices throughout their entire lifecycle for safety and efficacy. Distribution occurs through healthcare providers, pharmacies, clinical trial participation, and a self-service product listing website. Consumer-facing engagement runs through dedicated Facebook and Instagram channels for women's health (Bayer For Her) and general health awareness (Bayer4Health), plus a clinical trials website and an A-to-Z product portal. Pricing is not publicly disclosed.
Bayer AG is publicly traded (BAYRY OTC; BAYN Frankfurt) and Bayer India operates as a branch/subsidiary under it; the source material does not detail any specific Bayer-Zydus joint venture structure, and revenue figures for the India operation are not disclosed. The operating scope is restricted to India (South Asia), and the business is functionally a regional commercialization and distribution arm of a global pharmaceutical parent rather than a standalone technology or platform company.
Bayer Zydus Pharma firmographics
Firmographics- Name
- Bayer Zydus Pharma
- Legal name
- Bayer AG
- Website
- https://bayerzyduspharma.com
- Company type
- Public
- Founded year
- 1863
- Operating status
- Operating
- Short description
- Bayer India operates as the Indian pharmaceutical subsidiary of Bayer AG, marketing first-in-class innovative therapies across cardiovascular, diabetes, kidney, women's health, oncology, and ophthalmology through healthcare providers, pharmacies, and digital channels.
- Ownership category
- akta.pro rank
Bayer Zydus Pharma industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)
- akta.pro secondary industries
- Ophthalmology Pharmaceuticals (HLAIAAAL), Ophthalmology Specialty Pharmaceuticals (HLAIACAK)
Keywords
Where Bayer Zydus Pharma is headquartered
LocationHeadquarters
- HQ city
- Thane
- HQ country
- India
- HQ region
- Asia
Markets served
Bayer Zydus Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Distribution channels3 records
Marketing channels6 records
Bayer Zydus Pharma product offering
Product offeringCore offering
Bayer Zydus Pharma manufactures and distributes innovative, first-in-class pharmaceutical products across six therapeutic areas in India: Cardiovascular Health, Diabetes, Kidney Health, Women's Healthcare, Oncology, and Ophthalmology. The business operates under Bayer AG and leverages a global pharmacovigilance framework with over 1,000 experts to monitor product safety throughout each medicine's lifecycle, while also improving patient access to advanced treatments across the Indian market.
Product overview
Bayer Zydus Pharma operates as a pharmaceutical business segment within Bayer India, focused on introducing first-in-class, innovative therapies across key therapeutic areas including Cardiovascular Health, Diabetes, Kidney Health, Women's Healthcare, Oncology, and Ophthalmology. The company emphasizes bringing global innovative brands to the Indian market while maintaining a commitment to patient safety through pharmacovigilance practices. The product portfolio spans multiple specialty therapeutic areas rather than a single unified platform or modular product architecture.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiovascular Health Therapies Innovative branded pharmaceutical products for the treatment of cardiovascular conditions in Indian patients, distributed through healthcare providers and pharmacies. Global innovative brands in this area hold leadership positions in the Indian market.
- Diabetes Therapies Innovative branded pharmaceutical medications and treatments for diabetes management and blood sugar control in Indian patients, distributed through healthcare providers and pharmacies. Global innovative brands in this area hold leadership positions in the Indian market.
- Kidney Health Therapies Innovative branded pharmaceutical treatments for kidney disease and related complications in Indian patients, distributed through healthcare providers and pharmacies. Global innovative brands in this area hold leadership positions in the Indian market.
- Women's Healthcare Therapies Innovative branded pharmaceutical treatments for women's health conditions and reproductive health in Indian patients, distributed through healthcare providers and pharmacies. Global innovative brands in this area hold leadership positions in the Indian market.
- Oncology Therapies Innovative branded pharmaceutical treatments for cancer and tumor management in Indian patients, distributed through healthcare providers and pharmacies. Global innovative brands in this area hold leadership positions in the Indian market.
- Ophthalmology Therapies Innovative branded pharmaceutical treatments for eye diseases and vision impairment in Indian patients, distributed through healthcare providers and pharmacies. Global innovative brands in this area hold leadership positions in the Indian market.
Companies that use Bayer Zydus Pharma
Customer profileSegments6 records
Ideal customer profiles1 record
Bayer Zydus Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Bayer Zydus Pharma partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Bayer Zydus Pharma competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Customer concentration
Bayer Zydus Pharma social profiles
Digital presenceBayer Zydus Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bayer Zydus Pharma leadership team
Management profileNumber of profiles
Bayer Zydus Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bayer Zydus Pharma M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bayer Zydus Pharma
What does Bayer Zydus Pharma do?
Bayer Zydus Pharma manufactures and distributes innovative, first-in-class pharmaceutical products across six therapeutic areas in India: Cardiovascular Health, Diabetes, Kidney Health, Women's Healthcare, Oncology, and Ophthalmology. The business operates under Bayer AG and leverages a global pharmacovigilance framework with over 1,000 experts to monitor product safety throughout each medicine's lifecycle, while also improving patient access to advanced treatments across the Indian market.
Is Bayer Zydus Pharma a public or private company?
Bayer Zydus Pharma is a public company. It is classified as public and is currently operating.
When was Bayer Zydus Pharma founded?
Bayer Zydus Pharma was founded in 1863.
Where is Bayer Zydus Pharma based?
Bayer Zydus Pharma is headquartered in Thane, India, in the Asia region.
Does Bayer Zydus Pharma have an API?
No public API is recorded for Bayer Zydus Pharma.
What industry is Bayer Zydus Pharma in?
Bayer Zydus Pharma's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity), with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.